2020 US Microbiology Market: Supplier Shares and Sales Segment Forecasts
This report provides an overview of the US infectious disease diagnostics market, including market shares of leading suppliers by test, as well as volume and sales forecasts by market segment.
Contains 43 pages and 9 tables
Contains 43 pages and 9 tables
BUSINESS ENVIRONMENT
1. Health Care Expenditures
2. Cost Consciousness
3. Industry Consolidation
4. Managed Care
5. Hospitals
6. Admissions
7. Length of Stay
8. Industry Diversification
9. Physician Demographics
10. Population Aging
a. Chronic Illness
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases
11. Laboratory Regulations
MARKET STRUCTURE
1. Centralized Testing
a. Hospitals
b. Commercial/Private Laboratories
c. Blood Banks
1) Community and Regional Centers
2) Plasma Fractionation Centers
2. Decentralized Testing
a. Physician Offices/Group Practices
b. Point of Care Testing
c. Other Decentralized Testing Locations
MARKET SIZE, GROWTH, AND MAJOR SUPPLIERS’ MARKET SHARES
LIST OF TABLE
Test Volume Forecast by Market Segment
Sales Forecasts by Market Segment
AIDS Testing: Market Shares of Major Suppliers
Chlamydia Testing: Market Shares of Major Suppliers
Gonorrhea Testing: Market Shares of Major Suppliers
Hepatitis Testing: Market Shares of Major Suppliers
Rubella Testing: Market Shares of Major Suppliers
Streptococci Testing: Market Shares of Major Suppliers
Syphilis Testing: Market Shares of Major Suppliers
1. Health Care Expenditures
2. Cost Consciousness
3. Industry Consolidation
4. Managed Care
5. Hospitals
6. Admissions
7. Length of Stay
8. Industry Diversification
9. Physician Demographics
10. Population Aging
a. Chronic Illness
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases
11. Laboratory Regulations
MARKET STRUCTURE
1. Centralized Testing
a. Hospitals
b. Commercial/Private Laboratories
c. Blood Banks
1) Community and Regional Centers
2) Plasma Fractionation Centers
2. Decentralized Testing
a. Physician Offices/Group Practices
b. Point of Care Testing
c. Other Decentralized Testing Locations
MARKET SIZE, GROWTH, AND MAJOR SUPPLIERS’ MARKET SHARES
LIST OF TABLE
Test Volume Forecast by Market Segment
Sales Forecasts by Market Segment
AIDS Testing: Market Shares of Major Suppliers
Chlamydia Testing: Market Shares of Major Suppliers
Gonorrhea Testing: Market Shares of Major Suppliers
Hepatitis Testing: Market Shares of Major Suppliers
Rubella Testing: Market Shares of Major Suppliers
Streptococci Testing: Market Shares of Major Suppliers
Syphilis Testing: Market Shares of Major Suppliers
More Publications
2024 US Blood Typing, Grouping and Infectious Disease NAT Screening Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for over 40 Tests, Technology and Instrumentation Review
US$ 4,850.00
June 2020
465 pages
Succeeding in the 2020 US Molecular Diagnostics Market: Supplier Shares and Sales Segment Forecasts by Test, Competitive Intelligence, Emerging Technologies, Instrumentation and Opportunities
US$ 4,850.00
February 2020
1157 pages
2019-2023 U.S. POC/Decentralized Coagulation Testing Market: Supplier Shares and Strategies, Sales Forecasts, Emerging Technologies, Instrumentation Review--Physician Offices, Emergency Rooms, Operating Suites, ICU/CCUs, Cancer Clinics, Ambulatory Care Centers, Surgery Centers, Nursing Homes, Birth Centers
US$ 5,500.00
February 2019
418 pages
2017-2021 US Tumor Marker Testing Market: Emerging Opportunities and Growth Strategies for Suppliers
US$ 8,820.00
February 2017
620 pages
2019-2023 U.S. Hospital Hemostasis Diagnostics Market: Supplier Shares and Sales Segment Forecasts
US$ 6,300.00
February 2019
411 pages
